how glp 1 drugs work GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Mechanisms of action of GLP-1RA.

1998;275:G984G992

This multi-targeted approach helps reduce appetite by influencing the pathways involved in regulating food intake and energy expenditure: The hypothalamus receives full signals approximately 4 times longer per meal when taking Zepbound, significantly reducing overall food intake

Clinical trials report burping in approximately 1 to 3% of patients

Flash Glucose Monitoring Continues to Grow Despite the Presence of CGM Industry

16 Joint & Musculoskeletal Pain Overweight and obesity have a profound impact on overall physical function, musculoskeletal pain and both the development and progression of osteoarthritis

Concerns about the potential association between certain diabetes medications and cardiovascular disease meant that in 2010 the FDA approved liraglutide on condition that Novo Nordisk conduct a post-marketing study to evaluate the drug's effect on the incidence of major cardiovascular events (Nielsen, DeChiaro, Goldman)